These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24548552)

  • 1. Pathways to poor anticoagulation control.
    Razouki Z; Ozonoff A; Zhao S; Rose AJ
    J Thromb Haemost; 2014 May; 12(5):628-34. PubMed ID: 24548552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
    Rose AJ; Hylek EM; Ozonoff A; Ash AS; Reisman JI; Berlowitz DR
    J Thromb Haemost; 2010 Oct; 8(10):2182-91. PubMed ID: 20653840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
    Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation.
    Rizzi SA; Knight S; May HT; Woller SC; Stevens SM; Steinberg BA; Bair TL; Anderson JL; Muhlestein JB; Knowlton KU; Bunch TJ
    Am J Cardiol; 2021 Aug; 153():58-64. PubMed ID: 34176597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.
    Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):205-11. PubMed ID: 25944648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia.
    Yimer NS; Abiye AA; Hussen SU; Tadesse TA
    Clin Appl Thromb Hemost; 2021; 27():10760296211049786. PubMed ID: 34724849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    Semakula JR; Mouton JP; Jorgensen A; Hutchinson C; Allie S; Semakula L; French N; Lamorde M; Toh CH; Blockman M; Sekaggya-Wiltshire C; Waitt C; Pirmohamed M; Cohen K
    PLoS One; 2020; 15(1):e0227458. PubMed ID: 31995565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin for atrial fibrillation in community-based practise.
    Rose AJ; Ozonoff A; Henault LE; Hylek EM
    J Thromb Haemost; 2008 Oct; 6(10):1647-54. PubMed ID: 18853483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
    Vanerio G
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulants.
    Carrier M; Kimpton M; Wells PS; Langlois N; Kherani S; Le Gal G
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):812-5. PubMed ID: 24914740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
    Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism.
    Ambrus DB; Reisman JI; Rose AJ
    Thromb Res; 2016 Aug; 144():21-6. PubMed ID: 27270218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
    Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
    J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care.
    Rose AJ; Hylek EM; Berlowitz DR; Ash AS; Reisman JI; Ozonoff A
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):276-82. PubMed ID: 21505156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INR targets and site-level anticoagulation control: results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
    Rose AJ; Berlowitz DR; Miller DR; Hylek EM; Ozonoff A; Zhao S; Reisman JI; Ash AS
    J Thromb Haemost; 2012 Apr; 10(4):590-5. PubMed ID: 22288563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.